Monday, Citi analysts upgraded MKS Instruments (NASDAQ:MKSI) stock from Neutral to Buy, setting a price target of $130.00. The decision comes as the company is believed to be approaching a cyclical trough, signaling a potential upturn in its business cycle.
According to InvestingPro data, analyst targets range from $119 to $160, with 8 analysts recently revising their earnings expectations upward for the upcoming period. Citi's upgrade reflects confidence in MKS Instruments' diversified product portfolio within the semiconductor end market, particularly in etch and deposition processes.
The company is recognized for its ability to outperform in the semiconductor equipment sector during industry upcycles. This performance is attributed to increasing intensity in etch and deposition processes, where MKS Instruments holds significant market presence.
With an EBITDA of $871 million and strong liquidity metrics showing current assets exceeding short-term obligations by 3.4x, the company maintains a solid financial foundation. According to Citi, the company has already experienced inventory adjustments in logic and DRAM sectors, while corrections in the NAND segment may persist into the first half of 2025.
In addition to semiconductor equipment, MKS Instruments is also poised to capitalize on opportunities in the Electronics & Packaging (NYSE:PKG) market. The firm's analysts highlight the potential for MKS to leverage AI-driven advancements in areas such as advanced packaging substrates. Furthermore, the recent acquisition of Atotech is beginning to yield synergistic wins, contributing to the positive outlook for the company.
Citi's analysts emphasize the strategic moves MKS Instruments has made, which are expected to strengthen its market position as fundamentals stabilize. The upgrade to a Buy rating suggests that MKS Instruments is well-positioned to benefit from these developments and may offer an attractive opportunity for investors as the company navigates through the current market phase.
InvestingPro analysis reveals the company has maintained dividend payments for 14 consecutive years, demonstrating consistent shareholder returns. For deeper insights into MKS Instruments' financial health and growth prospects, including additional ProTips and comprehensive analysis, explore the full Pro Research Report available on InvestingPro.
In other recent news, MKS Instruments has seen numerous developments.
Morgan Stanley (NYSE:MS) maintained its Overweight rating on MKS Instruments, despite reducing its price target from $155 to $150. The company's 2025 revenue projections were revised from approximately $3.976 billion to $3.75 billion, and earnings per share (EPS) estimates for the same year were reduced from $7.76 to $7.20. However, the 2026 revenue forecast predicts a rise to $4.15 billion with EPS growing to $8.80.
MKS Instruments has also adopted new bylaws and initiated the declassification of its board, a process expected to culminate by the 2028 annual meeting of stockholders. The company reported a 1% sequential increase in Q3 revenue, totaling $896 million, and an operating income of $195 million.
Analysts from JPMorgan and Goldman Sachs have updated their stance on MKS Instruments. JPMorgan initiated coverage with an Overweight rating and a price target of $145.00, while Goldman Sachs maintained a Neutral rating and raised the stock target. MKS Instruments also announced the construction of a new semiconductor factory in Malaysia, aiming to diversify manufacturing risk. The company projected Q4 revenue to be between $910 million and $950 million, with semiconductor revenue expected at $380 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.